BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 8892718)

  • 1. A 61-year-old man with psoriasis.
    Baughman RD
    JAMA; 1996 Nov; 276(17):1421-8. PubMed ID: 8892718
    [No Abstract]   [Full Text] [Related]  

  • 2. Strategy to manage the treatment of severe psoriasis: considerations of efficacy, safety and cost.
    Feldman SR; Garton R; Averett W; Balkrishnan R; Vallee J
    Expert Opin Pharmacother; 2003 Sep; 4(9):1525-33. PubMed ID: 12943482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic treatment for moderate to severe psoriasis: estimates of failure rates and direct medical costs in a north-eastern US managed care plan.
    Feldman SR; Evans C; Russell MW
    J Dermatolog Treat; 2005 Feb; 16(1):37-42. PubMed ID: 15897166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cost-effectiveness analysis comparing methotrexate with PUVA therapy for moderate-severe psoriasis in the sanitary area of Badajoz].
    de Argila D; Rodríguez-Nevado I; Chaves A
    Actas Dermosifiliogr; 2007; 98(1):35-41. PubMed ID: 17374331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Moral and cost dilemma of a psoriasis patient.
    Abdul Ghaffar S; Finlay AY
    Br J Dermatol; 2007 Jan; 156(1):186-7. PubMed ID: 17199597
    [No Abstract]   [Full Text] [Related]  

  • 6. Malignancy concerns with psoriasis treatments using phototherapy, methotrexate, cyclosporin, and biologics: facts and controversies.
    Naldi L
    Clin Dermatol; 2010; 28(1):88-92. PubMed ID: 20082957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The annual cost of psoriasis.
    Sander HM; Morris LF; Phillips CM; Harrison PE; Menter A
    J Am Acad Dermatol; 1993 Mar; 28(3):422-5. PubMed ID: 8445058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost comparison of psoriasis treatments.
    Mikhael D; Babcock K; DesGroseilliers JP
    J Cutan Med Surg; 2009; 13(6):303-7. PubMed ID: 19919807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of moderate-to-severe psoriasis treatment.
    Miller DW; Feldman SR
    Expert Opin Pharmacother; 2006 Feb; 7(2):157-67. PubMed ID: 16433581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapeutic strategies against psoriasis. Skin to hide -- and how do you free your patients from it].
    Stiefelhagen P
    MMW Fortschr Med; 2007 Sep; 149(35-36):12-4. PubMed ID: 17944277
    [No Abstract]   [Full Text] [Related]  

  • 11. The cost-effectiveness and cost of treatment failures associated with systemic psoriasis therapies.
    Pearce DJ; Nelson AA; Fleischer AB; Balkrishnan R; Feldman SR
    J Dermatolog Treat; 2006; 17(1):29-37. PubMed ID: 16467021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in psoriasis treatment.
    Feldman S
    Dermatol Online J; 2000 Sep; 6(1):4. PubMed ID: 11328614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review of home phototherapy.
    Rajpara AN; O'Neill JL; Nolan BV; Yentzer BA; Feldman SR
    Dermatol Online J; 2010 Dec; 16(12):2. PubMed ID: 21199628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Current treatment of psoriasis. The proven and the new in the treatment of psoriasis].
    Krebs A
    Ther Umsch; 1967 Nov; 24(11):451-9. PubMed ID: 5600418
    [No Abstract]   [Full Text] [Related]  

  • 15. The burden of illness associated with psoriasis: cost of treatment with systemic therapy and phototherapy in the US.
    Crown WH; Bresnahan BW; Orsini LS; Kennedy S; Leonardi C
    Curr Med Res Opin; 2004 Dec; 20(12):1929-36. PubMed ID: 15701211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of clinical and cost-effectiveness of psoralen + ultraviolet A versus psoralen + sunlight in the treatment of chronic plaque psoriasis in a developing economy.
    Aggarwal K; Khandpur S; Khanna N; Sharma VK; Pandav CS
    Int J Dermatol; 2013 Apr; 52(4):478-85. PubMed ID: 23431966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Balneo phototherapy for psoriasis. Modern application of an age-old treatment.
    Mikula C
    Adv Nurse Pract; 2003 Jan; 11(1):53-6. PubMed ID: 12630261
    [No Abstract]   [Full Text] [Related]  

  • 18. Health care resource use, productivity, and costs among patients with moderate to severe plaque psoriasis in the United States.
    Schaefer CP; Cappelleri JC; Cheng R; Cole JC; Guenthner S; Fowler J; Johnson S; Mamolo C
    J Am Acad Dermatol; 2015 Oct; 73(4):585-593.e3. PubMed ID: 26253364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Equating topical treatment of severe psoriasis to keeping money in a mattress.
    Alikhan A; Sodhi N; Feldman SR
    J Dermatolog Treat; 2009; 20(1):1-2. PubMed ID: 19127480
    [No Abstract]   [Full Text] [Related]  

  • 20. Traditional therapies in the management of moderate to severe chronic plaque psoriasis: an assessment of the benefits and risks.
    Naldi L; Griffiths CE
    Br J Dermatol; 2005 Apr; 152(4):597-615. PubMed ID: 15840088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.